Bavarian Nordic, a vaccine maker, agrees to a $3 billion buyout by a consortium led by Nordic Capital and Permira.
Warner Bros. Discovery to split into two separate companies, addressing debt and providing strategic flexibility.
Liver cancer cases expected to nearly double by 2050, driven mainly by obesity, alcohol, and viral hepatitis, but over 60% are preventable through public health measures.
Bavarian Nordic, a vaccine maker, agrees to a $3 billion buyout by a consortium led by Nordic Capital and Permira.
Warner Bros. Discovery to split into two separate companies, addressing debt and providing strategic flexibility.
Liver cancer cases expected to nearly double by 2050, driven mainly by obesity, alcohol, and viral hepatitis, but over 60% are preventable through public health measures.